Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 15.10.2019 Börsentäglich über 12.000 News von 613 internationalen Medien
Investoren zahlen Prämie: Fura Gems schließt Kapitalrunde über 26,8 Mio. CAD ab
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Xconomy

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaFDA OKs Lilly's Lasmiditan, First New Acute Migraine Drug in Decades
FrVir Bio's IPO Brings In $143M for Tests of Hepatitis B Drug and More
FrBio Roundup: Nobel Prizes, Placebo Effect Rises, ICER's Fire & More
DoUCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
DoThe Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It?
MiWI Watchlist: Epic, Shine, Venture Investors, Stratatech & More
MiFive Years After Y Combinator First Admits Biotechs, They're Dug In
MiPharma, Biotech VC Investments Continue Shift to Early Stage Deals
08.10.LabFellows Looks to Become "Operating System" For Life Sciences Cos.
08.10.Catch Duchenne Patient Power, Phil Sharp & More Next Week at The Broad
08.10.With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues
08.10.Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
07.10.Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer For $250M
07.10.Precision IBD Rebrands as Prometheus and Strikes R&D Deal With Takeda
07.10.Unpack Digital Health's Progress & Pitfalls at X·CON on Oct. 22
04.10.Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
04.10.Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More
04.10.After Brain Cancer Drug Fails, Tocagen to Cut More Than Half of Staff
03.10.Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
03.10.Icosavax Lands $51M to Bring Vaccine for Respiratory Virus to Clinic
03.10.Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
02.10.Viscient Bio Proposes Organovo Merger to Tackle NASH and Go Beyond
01.10.Can Ford's Self-Driving Car Business Improve Austin's Traffic Woes?
01.10.Molecular Assemblies Raises $12M to Advance Enzymatic DNA Synthesis
01.10.Biogen's Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO